These are higher than the thresholds of >10% that are used to define HER2 3+ using IHC and HER2/CEP17 ratio of 2 in IHC 2+ patients, and which are conventionally used to define HER2-positivity in gastric cancers [17]. Here, ERBB2 is linked to gastric cancer.